Comparative analysis of prognostic indicators of aspergillosis in haematological malignancies and HIV infection

Journal of Infection

Volumn 34, Issue 1, 1997, Pages 55-60

  Tumbarello, M ^a   Tacconelli, E ^a   Pagano, L ^a   Ortu La Barbera, E ^a   Morace, G ^a   Cauda, R ^a   Leone, G ^a   Ortona, L ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ITRACONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ASPERGILLOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HEMOPTYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NEUTROPENIA; PROGNOSIS; PROSPECTIVE STUDY; RESPIRATORY FAILURE; RISK FACTOR;

EID: 0031039126     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(97)80010-2     Document Type: Article

References (27)

1. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990; 12: 1147-1201.
2. Kuhlman JE, Fishman EK, Burch PA, Karp JE, Zerhouni EA, Siegelman SS. Invasive pulmonary aspergillosis in acute leukaemia. The contribution of CT to early diagnosis and aggressive management. Chest 1987; 92: 95-99.
3. Gerson GL, Talbot TH, Hurwitz S, Strom BL, Kusk EJ, Cassileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in acute leukaemia. Ann Intern Med 1984; 100: 345-351.
4. Gustafson TL, Shaffner Lavely GB, Stratton CW, Johnson HK, Hutcheson RH. Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis 1983; 148: 230-238.
5. Meyer RD, Young LS, Yu B. Aspergillosis complicating neoplastic disease. Am J Med 1973; 54: 6-15.
6. Krick JA, Remington JS. Opportunistic invasive fungal infections in patients with leukaemia and lymphoma. Clin Haematol 1976; 5: 249-310.
7. Shpilberg O, Douer D, Goldschmied-Reouven A, Block C, Ben-Bassat I, Ramot B. Invasive aspergillosis in neutropenic patients with haematological disorders. Leuk Lymph 1991; 4: 257-262.
8. Just-Nubling G, Helm EB, Laubenberger C et al. The incidence of colonisation and invasive disease in a population of AIDS patients with Aspergillus species. In: Proceedings of the Sixth International Conference on AIDS. San Francisco, 1990.
9. Klapholz A, Salomon N, Perlman DC, Talavera W. Aspergillosis in the Acquired Immunodeficiency Syndrome. Chest 1991; 100: 1614-1618.
10. Tumbarello M, Ventura G, Caldarola G, Morace G, Cauda R, Ortona L. An emerging opportunistic infection in HIV patients; a retrospective analysis of 11 cases of pulmonary aspergillosis. Eur J Epidemiol 1993; 9: 638-644.
11. Mertins SD, Cauda R. The role of polymorphonuclear leukocytes in infection by retroviruses with emphasis on the human immunodeficiency virus. Viral Immunol 1990; 3: 173-177.
12. Lazzarin A, Uberti Foppa C, Galli M et al. Impairment of polymorphonuclear leukocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome. Clin Exp Immunol 1986; 65: 105-111.
13. Shafner A. Acquired immune deficiency syndrome: is disseminated aspergillosis predictive of underlying cellular immune deficiency? J Infect Dis 1984; 149: 828-829.
14. Burch PA, Karp JE, Merz WG, Kuhlman JE, Fishman EK. Favourable outcome of invasive aspergillosis in patients with acute leukaemia. J Clin Oncol 1987; 15: 1985-1993.
15. Tumbarello M, Pagano L, Ventura G, Ortu La Barbera E, Morace G, Cauda R. Different characteristics of pulmonary aspergillosis in immunocompromised patients. In: Proceedings of the Sixth International Congress of Infectious Diseases. Prague, 1994.
16. Miller WT, Sais GJ, Frank I, Gefter WB, Aronchick JM, Miller WT. Pulmonary aspergillosis in patients with AIDS. Clinical and radiological correlations. Chest 1994; 105: 37-44.
17. Ribrag V, Dreyfus F, Venot A, Leblong V, Lanore JJ, Varet B. Prognostic factors of invasive pulmonary aspergillosis in leukaemic patients. Leuk Lymph 1993; 10: 317-321.
18. Centers for Diseases Control. 1992 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescent and adults. MMWR 1992: 41-47.
19. Minamoto GY, Barlett TF, Venderm Els NJ. Invasive aspergillosis in patients with AIDS. Clin Infect Dis 1992; 14: 66-74.
20. Khoo SH, Denning DW. Invasive aspergillosis in patients with AIDS. Clin Infect Dis 1994; 19 (Suppl. 1): 41-48.
21. Sing N, Yu VL, Rihs JD. Invasive aspergillosis in AIDS. South Med J 1991; 84: 822-827.
22. Grosse G, Staib F, Seibold M, Heise M, Artigas J. Invasive aspergillosis - an AIDS typical opportunistic infection? In: Proceedings of the Fifth International Conference on AIDS. Montreal, 1989.
23. Gordin FM, Simon GL, Wofsy CB, Mills J. Adverse reactions to trimethoprim-sulfametoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1984; 100: 495-499.
24. Jacobson MA, O'Donnell JJ, Porteous D, Brodie HR, Feigal D, Mills J. Retinal and gastrointestinal disease due to cytomegalovirus in patients with acquired immunodeficiency syndrome: prevalence, natural history and response to therapy. Q J Med 1988; 254: 473-586.
25. Denning DW, Tucker RM, Hanson LH, Steven DA. Treatment of invasive aspergillosis with itraconazole. Am J Med 1989; 86: 791-800.
26. Denning DW, Lee JY, Hostetler JS et al. NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 1994; 97: 135-144.
27. Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Steven DA. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. New Engl J Med 1991; 324: 654-662.